Novel tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof

Details for Australian Patent Application No. 2001288346 (hide)

Owner Albert Einstein Healthcare Network

Inventors Daskal, Ierachimiel; Kwok, Simon

Agent Pizzeys

Pub. Number AU-B-2001288346

PCT Pub. Number WO02/16385

Priority 60226993 22.08.00 US

Filing date 22 August 2001

Wipo publication date 4 March 2002

Acceptance publication date 3 November 2005

International Classifications

C07H 021/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 001/20 Micro-organisms, e.g. protozoa - Bacteria

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 015/00 Mutation or genetic engineering

C07K 001/00 General processes for the preparation of peptides

Event Publications

3 November 2005 Application Accepted

  Published as AU-B-2001288346

2 March 2006 Standard Patent Sealed

19 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001288347

2001288345